Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia

NCT00034801 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 378

Last updated 2006-07-19

No results posted yet for this study

Summary

This is a research study comparing the safety and efficacy of two active study medications

Conditions

Interventions

DRUG

olanzapine

DRUG

ziprasidone

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Completion
2003-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00034801 on ClinicalTrials.gov